MARC보기
LDR01592nmm uu200421 4500
001000000331623
00520240805164747
008181129s2018 |||||||||||||||||c||eng d
020 ▼a 9780438380158
035 ▼a (MiAaPQ)AAI10931518
035 ▼a (MiAaPQ)ucla:17183
040 ▼a MiAaPQ ▼c MiAaPQ ▼d 248032
0820 ▼a 540
1001 ▼a Plamthottam, Sheba.
24510 ▼a Formulation and Development of Clinically Relevant Drugs.
260 ▼a [S.l.] : ▼b University of California, Los Angeles., ▼c 2018
260 1 ▼a Ann Arbor : ▼b ProQuest Dissertations & Theses, ▼c 2018
300 ▼a 201 p.
500 ▼a Source: Dissertation Abstracts International, Volume: 80-01(E), Section: B.
500 ▼a Adviser: Jeffrey I. Zink.
5021 ▼a Thesis (Ph.D.)--University of California, Los Angeles, 2018.
520 ▼a This dissertation makes contributions to the fields of anticancer drug formulation, synthesis and applications of nanoparticle adjuvants, and structure-activity relationships in drug discovery. Many drugs that are promising clinical candidates a
590 ▼a School code: 0031.
650 4 ▼a Chemistry.
650 4 ▼a Nanoscience.
650 4 ▼a Pharmacology.
690 ▼a 0485
690 ▼a 0565
690 ▼a 0419
71020 ▼a University of California, Los Angeles. ▼b Chemistry 0153.
7730 ▼t Dissertation Abstracts International ▼g 80-01B(E).
773 ▼t Dissertation Abstract International
790 ▼a 0031
791 ▼a Ph.D.
792 ▼a 2018
793 ▼a English
85640 ▼u http://www.riss.kr/pdu/ddodLink.do?id=T15001045 ▼n KERIS
980 ▼a 201812 ▼f 2019
990 ▼a 관리자